Information Services Group (ISG), a leading global technology research and advisory firm, has positioned Indegene as a Leader in its Provider Lens for Life Sciences Digital Services in Commercial Operations – Digital Evolution (Service Providers) Quadrant 2026.

 

The recognition underscores the company’s growing influence in reshaping how life sciences organizations run commercial operations through AI, data, and digital platforms.

 

The ISG assessment highlights Indegene’s deep domain expertise, proprietary technology stack, and expanding use of AI and GenAI to drive more integrated, data-led commercial execution across the life sciences value chain.

 

“The ISG Provider Lens report evaluates service providers based on their ability to help biopharmaceutical, biotech, and medical technology companies modernize commercial operations across planning, content, engagement, analytics, and execution through digital, data, and AI-enabled models.”

 

According to ISG, Indegene stands out for its structured, capability-driven approach supported by its NEXT Technology Platform and Cortex. The report notes that these platforms enable workflow automation, structured content management, and more targeted healthcare professional engagement using data-driven insights.

 

“Indegene shows a focused and capability-driven approach to life sciences commercial operations, supported by its proprietary platforms such as the NEXT Technology Platform and Cortex. These assets enable structured content management, workflow automation and more targeted HCP engagement through data-driven insights. 

 

"The company’s long-standing domain experience is reflected in its ability to deliver across the commercial value chain, from planning to execution, with an emphasis on standardized processes and measurable outcomes. 

 

"Its use of AI and GenAI in areas such as engagement planning, forecasting and analytics, along with a broad partner ecosystem, indicates a steady shift toward more integrated and data-led commercial models,” said Rohan Sinha, Principal Analyst – Healthcare and Life Sciences, ISG.

 

Indegene’s commercial operations strategy focuses on replacing fragmented digital efforts with fully orchestrated, intelligence-led systems. Its NEXT Technology Platform and Cortex connect content, data, workflows, and engagement across channels, enabling more consistent execution, improved efficiency, and stronger HCP interactions.

 

“ISG’s recognition as a Leader affirms our belief that the future of life sciences commercial operations will be intelligence-led and AI-native by design.” said Vivek Ghai, EVP, Indegene. 

 

“As the industry accelerates toward fully connected, data-driven ecosystems, we are shaping this transformation - enabling our clients to operationalize data and analytics into real-world outcomes at scale, with speed, precision, and consistency.”

 

This marks the third consecutive year of recognition from ISG, reinforcing Indegene’s position as a key partner for life sciences companies modernizing commercial operations through digital, data, and AI-led transformation.